Showing results (61-70 of 202) with videos related to
Sort By:
Pageof 21
Clinical Chemistry|July 1, 1988
Modified TDx assay for cyclosporine and metabolites, for use with whole-blood samplesW Vogt, I WelschWiener Klinische Wochenschrift. Supplementum|January 1, 1992
[Observations on the cost effectiveness of various methods of electrolyte determination]S L Braun, W VogtKlinische Wochenschrift|March 15, 1978
Influence of steroids on urea-cycle enzymes in chronic human liver diseaseK P Maier, H Talke, H Heimsoeth, et al.Leber, Magen, Darm|August 1, 1982
[Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?]K P Maier, H Lepiorz, H Berthold, et al.Zeitschrift Fur Immunitatsforschung. Immunobiology|November 1, 1976
Purification and some properties of factor D of the human properdin systemL Dieminger, W Vogt, R LynenBritish Journal of Pharmacology|January 1, 1985
Pharmacological characterization of the slow component of deactivation of guinea-pig isolated ileum to the spasmogenic action of C5adesArgB Damerau, J Roesler, W VogtNaunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1978
Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytesB Damerau, E Grünefeld, W VogtJournal of Clinical Anesthesia|September 1, 1997
Unindicated preoperative testing: ASA physical status and financial implicationsA W Vogt, L C HensonComplement (Basel, Switzerland)|January 1, 1984
'Inactivated' third component of complement (C3b-like C3; C3i) acquires C5 binding capacity and supports C5 activation upon covalent fixation to a solid surfaceW Vogt, B Lühmann, D HessePageof 21